Today is a very exciting day in prostate cancer as men with advanced prostate cancer and their families are given a new option. The FDA has approved Provenge, the first therapeutic vaccine for cancer ever approved by the agency. This approval may lead to a whole new approach to cancer therapy.
Women Against Prostate Cancer is excited to see a new treatment option being made available for patients. There is a great need for more options for advanced prostate cancer treatments, and this gives patients and physicians an innovative tool to potentially extend and improve their quality of life. Prostate cancer advocates, like you, are also owed a great thank you for all of the work that you did to help this process along. Patients should work with their healthcare providers to determine if they are an appropriate candidate for Provenge at this time.